Clinical Data That Lead to the FDA Approval of Zanubrutinib @MDAndersonNews

Clinical Data That Lead to the FDA Approval of Zanubrutinib @MDAndersonNews

obr

3 months
5 Views
Share Report
Want to watch this again later?
Sign in to add this video to a playlist. Login
0 0
Category:
Description:
Michael Wang, MD, Professor, Department of Lymphoma and Myeloma @MDAndersonNews offers his impression of the pivotal clinical data that lead to the FDA approval of zanubrutinib.
Up Next Autoplay